AtriCure, Inc. (ATRC)
55.81
+2.97
(+5.62%)
USD |
NASDAQ |
Oct 09, 16:00
55.85
+0.04
(+0.07%)
After-Hours: 20:00
AtriCure Cash from Operations (Quarterly) : 22.19M for June 30, 2026
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 22.19M |
| March 31, 2026 | -3.996M |
| December 31, 2025 | 20.03M |
| September 30, 2025 | 26.72M |
| June 30, 2025 | 21.62M |
| March 31, 2025 | -11.03M |
| December 31, 2024 | 4.767M |
| September 30, 2024 | 20.00M |
| June 30, 2024 | 8.24M |
| March 31, 2024 | -21.88M |
| December 31, 2023 | 4.03M |
| September 30, 2023 | 1.522M |
| June 30, 2023 | 3.011M |
| March 31, 2023 | -4.139M |
| December 31, 2022 | 0.046M |
| September 30, 2022 | -1.784M |
| June 30, 2022 | 4.229M |
| March 31, 2022 | -24.63M |
| December 31, 2021 | 0.301M |
| September 30, 2021 | -0.232M |
| June 30, 2021 | -4.533M |
| March 31, 2021 | -9.316M |
| December 31, 2020 | 3.953M |
| September 30, 2020 | 3.782M |
| June 30, 2020 | -11.55M |
| Date | Value |
|---|---|
| March 31, 2020 | -16.09M |
| December 31, 2019 | -3.529M |
| September 30, 2019 | -2.29M |
| June 30, 2019 | 3.745M |
| March 31, 2019 | -13.74M |
| December 31, 2018 | 0.985M |
| September 30, 2018 | 5.213M |
| June 30, 2018 | -0.935M |
| March 31, 2018 | -9.434M |
| December 31, 2017 | 1.478M |
| September 30, 2017 | 0.131M |
| June 30, 2017 | -1.057M |
| March 31, 2017 | -9.546M |
| December 31, 2016 | 0.761M |
| September 30, 2016 | 1.076M |
| June 30, 2016 | -6.025M |
| March 31, 2016 | -10.93M |
| December 31, 2015 | -4.08M |
| September 30, 2015 | 2.632M |
| June 30, 2015 | 2.514M |
| March 31, 2015 | -8.97M |
| December 31, 2014 | -2.013M |
| September 30, 2014 | -1.214M |
| June 30, 2014 | -3.975M |
| March 31, 2014 | -14.40M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Abbott Laboratories | 2.488B |
| Boston Scientific Corp. | 1.474B |
| AngioDynamics, Inc. | -15.33M |
| Alphatec Holdings, Inc. | 20.51M |
| Baxter International, Inc. | 285.00M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -3.766M |
| Cash from Financing (Quarterly) | 3.262M |
| Free Cash Flow | 53.11M |
| Free Cash Flow Per Share (Quarterly) | 0.3771 |
| Free Cash Flow to Equity (Quarterly) | 19.12M |
| Free Cash Flow to Firm (Quarterly) | 19.68M |
| Free Cash Flow Yield | 1.96% |